# Nuclide record opp-fap-pancreatic-staging (opportunity). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/opportunities/opp-fap-pancreatic-staging/>
  a schema:CreativeWork ;
  nuclide:kind "opportunity" ;
  schema:identifier "opp-fap-pancreatic-staging" ;
  schema:name "FAP imaging to stop futile pancreatic surgery"@en ;
  schema:alternateName "FAPI PET in PDAC"@en ;
  schema:description "Four in ten pancreatic cancer patients whose scans say the tumour can be removed turn out, once opened up, to have disease that cannot be removed. A scan that lights up the scar tissue around tumour deposits sees more of that hidden disease than the standard one."@en ;
  schema:url <https://nuclide.cc/opportunities/opp-fap-pancreatic-staging/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd009323.pub3/full>, <https://jnm.snmjournals.org/content/jnumed/65/2/206.full.pdf>, <https://clinicaltrials.gov/study/NCT05262855>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC11634952/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12607575/> ;
  nuclide:tag "unmet need first", "pancreas", "surgical selection", "stroma" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/pancreatic-cancer/> ;
  nuclide:technologies <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/fdg-pet/> ;
  nuclide:targets <https://nuclide.cc/targets/fap/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ga-68-fapi-46/>, <https://nuclide.cc/drugs/fap-2286/> .
